ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

USC Study Finds Increased Colon Cancer Risk For Sedentary Workers

April 13, 1984

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

August 27, 2004

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

AACR Receives Record Number of Abstracts

January 27, 1989